CLDI CALIDI BIOTHERAPEUTICS C

$1.13

CALIDI BIOTHERAPEUTICS C (CLDI) is expected to report earnings on November 12, 2026, after the market close.

CALIDI BIOTHERAPEUTICS C Reported Earnings
Thursday, August 13, 2026 · 4:30 PM ET
Earnings Date
Nov 12
Thursday · 4:15 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CALIDI BIOTHERAPEUTICS C

Calidi Biotherapeutics Inc. is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer with a novel stem cell-based therapy. Calidi Biotherapeutics Inc., formerly known as First Light Acquisition Group, is based in SAN DIEGO.

Charts powered in part by Lightweight Charts™ by TradingView.